Cravatex Intrinsic Value
Cravatex (CRAVATEX) median intrinsic value is ₹297.12 from 10 valuation models (range ₹148–₹470), vs current price ₹370.85 — -19.9% downside (Trading Above Median Value), margin of safety -24.8%. Read CRAVATEX dividend history for the complete payout history and dividend yield track record.
CRAVATEX Valuation Methods Summary — DCF, Graham Number & P/E
Cravatex intrinsic value across 10 models vs current price ₹370.85 — upside/downside and value range per method. Analyse CRAVATEX FII DII holdings to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹297.12 | ₹237.70 - ₹356.54 | -19.9% | EPS: ₹24.76, Sector P/E: 12x |
| Book Value Method | asset | ₹396.67 | ₹357.00 - ₹436.34 | +7.0% | Book Value/Share: ₹396.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹458.67 | ₹412.80 - ₹504.54 | +23.7% | Revenue/Share: ₹573.33, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹240.00 | ₹216.00 - ₹264.00 | -35.3% | EBITDA: ₹12.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹148.34 | ₹118.67 - ₹178.01 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹158.46 | ₹142.61 - ₹174.31 | -57.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹204.02 | ₹183.62 - ₹224.42 | -45.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹266.67 | ₹240.00 - ₹293.34 | -28.1% | ROE: 6.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹470.09 | ₹423.08 - ₹517.10 | +26.8% | EPS: ₹24.76, BVPS: ₹396.67 |
| Dividend Yield Method | dividend | ₹371.43 | ₹334.29 - ₹408.57 | +0.2% | DPS: ₹13.00, Target Yield: 3.5% |
CRAVATEX Intrinsic Value vs Market Price — All Valuation Models
Cravatex fair value range ₹148–₹470 vs current market price ₹370.85 across 10 valuation models. For current market price and key ratios, visit CRAVATEX stock price BSE.
CRAVATEX Intrinsic Value Analysis — Undervalued or Overvalued?
Cravatex median intrinsic value ₹297.12, current price ₹370.85 — Trading Above Median Value by 19.9%, margin of safety -24.8%.
What is the intrinsic value of CRAVATEX?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Cravatex (CRAVATEX) is ₹297.12 (median value). With the current market price of ₹370.85, this represents a -19.9% variance from our estimated fair value.
The valuation range spans from ₹148.34 to ₹470.09, indicating ₹148.34 - ₹470.09.
Is CRAVATEX undervalued or overvalued?
Based on our multi-method analysis, Cravatex (CRAVATEX) appears to be trading above median value by approximately 19.9%.
CRAVATEX Financial Health — Key Ratios vs Industry Benchmarks
Cravatex financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 69.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 6.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.18x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CRAVATEX Cash Flow Quality — Operating & Free Cash Flow
Cravatex operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹19 Cr | ₹19 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹144 Cr | ₹144 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |